Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Coagulation Activity and White Thrombus Formation in the Microminipig

NAOKI MIURA, HIROAKI KAWAGUCHI, TOMOKA NAGASATO, TOMONOBU YAMADA, TAKASHI ITO, HIROYUKI IZUMI, HISAYO SHAMESHIMA, NORIAKI MIYOSHI, AKIHIDE TANIMOTO and IKURO MARUYAMA
In Vivo May 2013, 27 (3) 357-361;
NAOKI MIURA
1Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI KAWAGUCHI
2Department of Veterinary Histopathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOKA NAGASATO
3Systems Biology in Thromboregulation, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
5Research Institute, Fujimori Kogyo Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMONOBU YAMADA
4Department of Molecular and Cellular Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
6Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd., Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI ITO
3Systems Biology in Thromboregulation, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI IZUMI
6Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd., Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HISAYO SHAMESHIMA
5Research Institute, Fujimori Kogyo Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORIAKI MIYOSHI
2Department of Veterinary Histopathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIDE TANIMOTO
4Department of Molecular and Cellular Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akit09@m3.kufm.kagoshima-u.ac.jp rinken@m3.kufm.kagoshima-u.ac.jp
IKURO MARUYAMA
3Systems Biology in Thromboregulation, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akit09@m3.kufm.kagoshima-u.ac.jp rinken@m3.kufm.kagoshima-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Swine are becoming increasingly attractive as animal models for clinical research and the recently developed Microminipig (MMPig) has emerged as a possible experimental animal model. In this study, we demonstrated age-dependent changes in hematological parameters and coagulation activity in healthy MMPigs (58 male and 67 females, aged 0-34 months), and investigated white thrombus formation (WTF) using an in vitro microchip flow-chamber system (four males and four females, aged 22-23 months). There was no clear sex or age-dependent differences in any hematological parameters. While activated partial thromboplastin time (APTT) was shorter than prothrombin time (PT), with APTT:PT of 0.88:1, microchip flow-chamber system analysis showed that WTF time was shorter than that in humans, suggesting a possible thrombotic tendency in the MMPig. These results could be useful to life science researchers in the use of the MMPig as an experimental model animal for thrombus formation.

  • Aging
  • porcine hematology
  • coagulation activity
  • thrombus formation
  • microminipig
  • minipig

Swine have been used extensively in biomedical research, with a significant increase in recent decades, more than 60,000 pigs having been used in a year in the EU (1, 2). Because of their physiological and anatomical similarity to humans (3), swine are becoming increasingly attractive as animal models for clinical research. The microminipig (Brand: MMPig; registered with the Japanese Ministry of Agriculture, Forestry and Fisheries as a novel variety of swine; Fuji Micra Inc., Shizuoka, Japan) has emerged as a possible experimental animal model for non-clinical pharmacological/toxicological use (4-6). A female minipig, “Catherine” (the MMPig “Eve”), was the outcome from mating a pot-bellied pig and another type of minipig (4). The body weight (BW) of a young mature MMPig is <10 kg, enabling easy handling (3, 7-9). Except for coagulation activity, prothrombin time (PT) and activated partial thromboplastin time (APTT), the major hematological and biochemical parameters in the MMPig are similar to those found in Göttingen and Yucatan minipigs (7). The aim of the current study was to measure age-dependent changes in hematological parameters and coagulation activity, and to investigate white thrombus formation (WTF) in healthy MMPigs, using an automated microchip flow-chamber system.

Materials and Methods

Animals. All animals were maintained in the same animal unit at 24±3°C and relative humidity at 50±20%, with a 12 h light/dark cycle, and a maintenance space of 0.5-1.2 m2/animal. The amount of porcine diet (Marubeni Nisshin Feed Co.) provided was set according to age and body weight: 4-8%, 2-4%, and 1-3% of BW corresponding to 1 to 3 months, 4 to 6 months, and 7 months and older, respectively. The diet was composed of >13.0% crude protein, >2.0% crude fat, <8.0%crude fiber, <10.0% crude ash, >1.1% calcium, and >0.9% phosphorus. Tap water was available ad libitum. The animals used in this study were in good health and free of clinical signs of illness. They required no treatment or medication other than vaccination during the study. Data are presented as the mean±SD, and statistical analysis of differences was by F-test, and Student's t-test or Welch's t-test, at a significance level of p<0.05.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A: The flow-pressure waveform pattern during white thrombus formation (WTF). The black line represents the increasing pressure resulting from occlusion in the microchip flow-chamber by white thrombus formation. B: A typical image of white thrombus in the microchip flow-chamber. Open arrowheads indicate the initial small thrombus and closed arrowheads indicate mature WTF. C: The lag time for flow pressure to increase to 80 kPa in microminipigs measured by in vitro micro flow chamber system. p-Value is 0.4433 by the Student's t-test.

Blood collection. Blood samples were collected from the cranial vena cava of 125, fasted, conscious animals (58 males and 67 females) aged 0 to 34 months. For measurement of 23 hematological parameters, except PT and APTT, 1 ml of blood was collected with EDTA-2K as an anticoagulant and applied to an automatic analyzer (ADVIA 120, Siemens Healthcare Diagnostics Manufacturing Ltd., Munich, Bavaria, Germany). For measurement of PT and APTT, 1.5 ml of blood was collected with 150 μl of 3.8 w/v% sodium citrate solution as an anticoagulant. Plasma was obtained by centrifugation (4°C, 1,710 × g, for 15 min) and analyzed with an automatic analyzer (CA-7000, Sysmex Corporation, Kobe, Japan).

WTF assay. WTF assays were performed using an automated microchip flow-chamber system as previously stated (10). Blood (n=4 males and 4 females, aged 22 to 23 months, considered the most likely age for use in life science research) was collected into a tube containing 3.2% sodium citrate and mixed with 20 μl of 0.3 M CaCl2 containing 1.25 mg/ml of corn trypsin inhibitor immediately before application to the microchip. The mixture of blood and corn trypsin inhibitor was perfused over a microchip capillary coated with collagen and tissue thromboplastin at a flow rate of 10 μl/min. The WTF process is monitored by flow pressure changes in the capillary with a pressure sensor. As WTF spreads on the coated surface, the capillary is gradually occluded, increasing the flow pressure (Figure 1A and B). We calculated that the lag time for the flow pressure increase tothe 80 kPa (T80) from baseline, representing almost complete occlusion of the capillary by WTF.

Results

Hematological parameters and coagulation activity. Age-dependent hematological parameters and coagulation activity are listed in Tables I and II. Given statistical significance of p<0.01, hemoglobin values at age 3 to 5 months, APTT at age 9 to 12 months, and Red blood cell (RBC) at age 25 to 34 months were significantly lower and shorter respectively in females than those in males. Mean corpuscular hemoglobin concentration (MCHC) was higher in females aged 13 to 24 months. In the White blood cell (WBC) population, the basophil count was higher in females aged 13 to 24 months, corresponding to a higher basophil ratio and lower neutrophil ratio. No major parameter, including RBC and WBC, showed clear biological sex and/or age differences. APTT was shorter than PT (mean values) and the ratio of APTT to PT was approximately 0.88:1 in males, females, and both at the relevant age points.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Age-specific values in hematology in microminipigs.

WTF assay. The lag times for the flow pressure to increase by 80 kPa (T80) for male and female MMPigs was 386.3±50.4 min and 422.8±58.2 min, respectively (Figure 1C). There was no significant difference in T80 between the two groups (p=0.4433), indicating similar characteristics in thrombus formation in both males and females.

Discussion

Since the minipig is physiologically and anatomically similar to human, it is a suitable species for toxicological/pharmacological studies. However, despite continued efforts by breeders, minipigs are not yet widely used in life science research and one possible reason is the lack of reference values (11). We have reported reference values for hematological parameters in the newly-developed MMPig, the world's smallest minipig (7). In this study, we analyzed age-dependent changes in hematological and coagulation parameters for the MMPig to provide detailed information. There were no sex or age-dependent changes in hematological parameters during the experimental period. This indicates that there are no major differences in hematological parameters compared to those previously reported for the minipig (6).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Age-specific values in hematology in microminipigs.

However, the ratio of APTT to PT was different from that in other experimental animals. Although PT and APTT are commonly used as plasma-based assays for the assessment of coagulation activity in experimental animals, the exact time of each assay differs between species (12). In all species, except the rat (F344 strain), APTT is reported to be longer than PT and the ratio of APTT to PT is between 2:1 and 3:1. By contrast, in the MMPig, APTT is shorter than PT and the ratio is 0.88:1. Short APTT (11.2±1.0 s), as observed in the MMPig, is a unique characteristic when compared with previously reported results for minipigs; the APTT in the Gottingen minipig is in the range of 26 to 46 s and that for the Yucatan minipig an average of 15.46±1.15 s. APTT is longer than PT in both minipig species, consistent with other species (13, 14). Although it will be necessary to elucidate the biological mechanism of the shorter APTT observed in the MMPig, this hyper-coagulable response to the intrinsic pathway may suggest a thrombotic tendency in the MMPig.

APTT is assayed to evaluate the coagulation pathway, but does not fully reflect the interaction of coagulation factors or platelets in vivo. The newly-developed microchip-based flow chamber system (WTF assay) mimics in vivo blood flow and is influenced by both platelet activation and coagulation reactions over the collagen/tissue thromboplastin-coated surface (10). In this experiment, we used flow rates of 10 μl/min, corresponding to initial wall shear rates of 600× s−1, which simulates arterial blood flow in small to medium-sized arteries (15). T80 in the MMPig was 404.5±57.4 min compared with 558±90 in man, and the WTF assay indicated that white thrombus formation in the microminipig was markedly more rapid than that in human (10). This result further supports the conjecture that the MMPig has a thrombotic tendency, at least by in vitro thrombus formation assay.

Conclusion

In this study, we demonstrated age-dependent changes in hematological and coagulation parameters for MMPigs. All hematological parameters were within the normal range, with no major sex or age differences. APTT in the MMPig was shorter than PT and the ratio of APTT to PT was 0.88:1. We also investigated the thrombus formation activity and indicated a thrombotic tendency in the MMPig. These results could be useful to life science researchers in regard to the use of the MMPig as an experimental model animal for thrombus formation.

Acknowledgements

This work was partly supported by Health Labour Sciences Research Grant (no. 33361105) from the Ministry of Health, Labour and Welfare of Japan (to NM, HK, and AT), Adaptable and Seamless Technology transfer Program (A-Step No. AS2316907E) from the Ministry of Education Culture, Sports, Science and Technology of Japan (to AT and HK), Suzuken Memorial Foundation (to NM, HK and AT) and SENSHIN Medical Research Foundation (to NM, HK and AT). We are grateful to Mr. T. Motokado (SNBL, Ltd.), Dr. T. Nishimura, and Mr. N. Kaneko (Fuji Micra Inc.) for their advice and valuable technical assistance.

Footnotes

  • ↵* These Authors contributed equally to this study.

  • Conflicts of Interest

    TN and HS are employees of Fujimori Kogyo Co., Ltd. TI and IM hold endowed faculty positions in thrombosis research and have received funds from Medipolis Medical Research Institute, Shin Nippon Biomedical Laboratories, Asahi Kasei Pharma, and Asahi Kasei Medical.

  • Received March 11, 2013.
  • Revision received April 5, 2013.
  • Accepted April 5, 2013.
  • Copyright © 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Bollen PJA,
    2. Hansen AK,
    3. Rasmussen HJ,
    4. Suckow MA
    1. Bollen PJA,
    2. Hansen AK,
    3. Rasmussen HJ
    : Important biological features. pp. 1-13. In: The Laboratory Swine, 2nd ed.Bollen PJA, Hansen AK, Rasmussen HJ, Suckow MA (eds.). CRC Press, New York, USA. pp. 1-13, 2010.
  2. ↵
    1. Svendsen O
    : The minipig in toxicology. Exp Toxicol Pathol 57: 335-339, 2006.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Kawaguchi H,
    2. Miyoshi N,
    3. Miura N,
    4. Fujiki M,
    5. Horiuchi M,
    6. Izumi Y,
    7. Miyajima H,
    8. Nagata R,
    9. Misumi K,
    10. Takeuchi T,
    11. Tanimoto A,
    12. Yoshida H
    : Microminipig, a non-rodent experimental animal optimized for life science research:novel atherosclerosis model induced by high fat and cholesterol diet. J Pharmacol Sci 115: 115-121, 2011.
    OpenUrlCrossRef
  4. ↵
    1. Kaneko N,
    2. Itoh K,
    3. Sugiyama A,
    4. Izumi Y
    : 2011. Microminipig, a non-rodent experimental animal optimized for life science research: preface. J Pharmacol Sci 115: 112-114, 2011.
    OpenUrlCrossRef
    1. Murayama N,
    2. Kaneko N,
    3. Horiuchi K,
    4. Ohyama K,
    5. Shimizu M,
    6. Ito K,
    7. Yamazaki H
    : Cytochrome P450-dependent drug oxidation activity of liver microsomes from Microminipigs, a possible new animal model for humans in non-clinical studies. Drug Metab Pharmacokinet 24: 404-408, 2009.
    OpenUrlPubMed
  5. ↵
    1. Sugiyama A,
    2. Nakamura Y,
    3. Akie Y,
    4. Saito H,
    5. Izumi Y,
    6. Yamazaki H,
    7. Kaneko N,
    8. Itoh K
    : Microminipig, a non-rodent experimental animal optimized for life science research: In vivo proarrhythmia models of drug-induced long QT syndrome: development of chronic atrioventricular block model of microminipig. J Pharmacol Sci 115: 122-126, 2011.
    OpenUrl
  6. ↵
    1. Kawaguchi H,
    2. Yamada T,
    3. Miura N,
    4. Takahashi Y,
    5. Yoshikawa T,
    6. Izumi H,
    7. Kawarasaki T,
    8. Miyoshi N,
    9. Tanimoto A
    : Reference values of hematological and biochemical parameters for the world smallest microminipigs. J Vet Med Sci 74: 933-936, 2012.
    OpenUrlCrossRefPubMed
    1. Miyoshi N,
    2. Horiuchi M,
    3. Inokuchi Y,
    4. Miyamoto Y,
    5. Miura N,
    6. Tokunaga S,
    7. Fujiki M,
    8. Izumi Y,
    9. Miyajima H,
    10. Nagata R,
    11. Misumi K,
    12. Takeuchi T,
    13. Tanimoto A,
    14. Yasuda N,
    15. Yoshida H,
    16. Kawaguchi H
    : Novel microminipig model of atherosclerosis by high fat and high cholesterol diet, established in Japan. In Vivo 24: 671-680, 2010.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Takeishi K,
    2. Horiuchi M,
    3. Kawaguchi H,
    4. Deguchi Y,
    5. Izumi H,
    6. Arimura E,
    7. Kuchiiwa S,
    8. Tanimoto A,
    9. Takeuchi T
    : Acupuncture improves sleep conditions of minipigs representing diurnal animals through an anatomically similar point to the acupoint (GV20) effective for humans. Evid Based Complement Alternat Med, doi: 10.1155/2012/472982.
  8. ↵
    1. Hosokawa K,
    2. Ohnishi T,
    3. Kondo T,
    4. Fukasawa M,
    5. Koide T,
    6. Maruyama I,
    7. Tanaka KA
    : A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost 9: 2029-2037, 2011.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Tumbleson ME,
    2. Badger TM,
    3. Baker PC,
    4. Hutcheson DP
    : Systematic oscillations of serum biochemic and hematologic parameters in Sinclair(S-1) miniature swine. J Anim Sci 35: 48-50, 1972.
    OpenUrlPubMed
  10. ↵
    1. Tabata H
    . Nakamura S and Matsuzawa T: Some species differences in the false prolongation of prothrombintimes and activated partial thromboplastin times in toxicology. Comp Haematol Int 5: 140-144, 1995.
    OpenUrlCrossRef
  11. ↵
    1. Rispat G,
    2. Slaoui M,
    3. Weber D,
    4. Salemink P,
    5. Berthoux C,
    6. Shrivastava R
    : Haematological and plasma biochemical values for healthy Yucatan micro pigs. Lab Animal 27: 368-373, 1993.
    OpenUrl
  12. ↵
    1. Jørgensen KD,
    2. Ellegaard L,
    3. Klastrup S,
    4. Svendsen O
    : Haematological and clinical chemical values in pregnant and juvenile Göttingen minipigs. Scand J. Lab Anim Sci 25: 181-190, 1998.
    OpenUrl
  13. ↵
    1. Slack SM,
    2. Cui Y,
    3. Turitto VT
    : The effects of flow on blood coagulation and thrombosis. Thromb Haemost 70: 129-34, 1993.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

In Vivo: 27 (3)
In Vivo
Vol. 27, Issue 3
May-June 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Coagulation Activity and White Thrombus Formation in the Microminipig
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Coagulation Activity and White Thrombus Formation in the Microminipig
NAOKI MIURA, HIROAKI KAWAGUCHI, TOMOKA NAGASATO, TOMONOBU YAMADA, TAKASHI ITO, HIROYUKI IZUMI, HISAYO SHAMESHIMA, NORIAKI MIYOSHI, AKIHIDE TANIMOTO, IKURO MARUYAMA
In Vivo May 2013, 27 (3) 357-361;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Coagulation Activity and White Thrombus Formation in the Microminipig
NAOKI MIURA, HIROAKI KAWAGUCHI, TOMOKA NAGASATO, TOMONOBU YAMADA, TAKASHI ITO, HIROYUKI IZUMI, HISAYO SHAMESHIMA, NORIAKI MIYOSHI, AKIHIDE TANIMOTO, IKURO MARUYAMA
In Vivo May 2013, 27 (3) 357-361;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • NR6A1 Allelic Frequencies as an Index for both Miniaturizing and Increasing Pig Body Size
  • Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis
  • Diurnal Variation of Melatonin Concentration in the Cerebrospinal Fluid of Unanesthetized Microminipig
  • Corpus luteum Regression Induced by Prostaglandin F2{alpha} in Microminipigs During the Normal Estrous Cycle
  • The Microminipig as an Animal Model for Influenza A Virus Infection
  • Profiles of Reproductive Hormone in the Microminipig During the Normal Estrous Cycle
  • Comparison of the Genomic Sequence of the Microminipig, a Novel Breed of Swine, with the Genomic Database for Conventional Pig
  • Investigation of Necessity of Sodium Cholate and Minimal Required Amount of Cholesterol for Dietary Induction of Atherosclerosis in Microminipigs
  • Sex Differences of Serum Lipid Profile in Novel Microminipigs
  • Google Scholar

More in this TOC Section

  • Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer
  • Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo
  • TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma
Show more Experimental Studies

Similar Articles

Keywords

  • Aging
  • porcine hematology
  • coagulation activity
  • thrombus formation
  • Microminipig
  • Minipig
In Vivo

© 2021 In Vivo

Powered by HighWire